Ari Maizel

Chief Commercial Officer, Axsome Therapeutics, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$2.8M

Companies

Latest trade

Apr 22, 2026

Companies

Axsome Therapeutics, Inc.Chief Commercial Officer −$2.8M

Trades

AXSM Sold 7,500 shares at $182.42 · planned $1.4M Apr 22

AXSM Sold 7,500 shares at $184.44 · planned $1.4M Jan 21

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.